FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...
Cost Pen Needles from Owen Mumford Offer Pharmacies a Competitive Cash-Pay Option. MARIETTA, GEORGIA / ACCESS Newswire / April 2, 2025 / Owen Mumford is pleased to announce the launch of UnifineOTC, a ...
ORLANDO, FL / ACCESS Newswire / April 2, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is ...
AUSTIN, TEXAS / ACCESS Newswire / April 2, 2025 / Software Effective Solutions Corp. (OTC PINK:SFWJ), doing business as Medcana, is proud to announce the successful export of its first ...
Survey shows executives turning to automation, AI, and domestic production amid geopolitical and regulatory shifts TAMPA, ...
The Global Advanced Drug Delivery CDMO Market is expected to witness a healthy and a double-digit growth rate by 2027. Major ...
The global market for MRI-guided and focused ultrasound devices is on the cusp of substantial growth, driven by technological innovations and an increasing preference for non-invasive therapeutic ...
The global healthcare BPO services market is set to witness a growth rate of 9% in the next 5 years. Transition to ICD-10 ...
Boehringer Ingelheim today announced a continued rise in the number of patients it reached, 66 million in 2024, up 8.0% from the previous year. Development of its current product pipeline is well on ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
Ondine Biomedical Inc. reports that results from the first NHS deployment of Steriwave® nasal decolonization technology at Mid Yorkshire Teaching NHS Trust (Mid Yorks) have demonstrated a substantial ...
ZIONSVILLE, INDIANA / ACCESS Newswire / April 2, 2025 / Jabez Biosciences, Inc., a clinical-stage biopharmaceutical company dedicated to ushering in the future of cancer therapy, today announced that ...